ADVERTISEMENT

K-pop group NCT's Mark, members of Cosmic Girls, Cignature test positive for Covid-19 

Published Jul 25, 2022 06:32 pm

K-pop boy band NCT’s Mark and members of girl groups Cosmic Girls and Cignature tested positive for Covid-19 as South Korea experiences a surge in cases due to the Omicron BA.5 subvariant.

“NCT’s Mark was confirmed with Covid-19 today (25th),” SM Entertainment announced.

(Clockwise from top left) Cosmic Girls' Exy, NCT's Mark, Cosmic Girls' Yeoreum, and Cignature's Semi and Belle (Instagram, Twitter)

It explained that “Mark felt symptoms of abnormal condition this morning, so he immediately conducted a rapid antigen test and was confirmed with Covid-19.”

“Mark has completed the third round of the Covid-19 vaccine, and immediately suspended all schedules and is under self-isolation and home treatment according to the guidelines of the quarantine authorities,” the agency said.

As a result, the agency said, NCT Dream’s second solo concert “The Dream Show 2: In A Dream” scheduled on July 29 to 31 will be held with six members excluding Mark.

“We strictly follow quarantine guidelines, and we will do our best to focus on recovery, considering the health and safety of our artists as our top priority,” it said.

Cosmic Girls

Before Mark, girl group Cosmic Girls (WJSN) members Exy and Yeoreum tested positive for Covid-19 on July 24, according to Starship Entertainment, their agency.

“Exy and Yeoreum tested positive in the self-diagnosis kit test preemptively conducted to attend the schedule on the 24th, so they immediately went to the hospital and performed a rapid antigen test and PCR test, and were confirmed with Covid-19,” the agency said.

It added, “Exy and Yeoreum have completed up to the third dose of the Covid-19 vaccine, and currently have no symptoms other than mild sore throat and low fever, and are being treated at home according to the guidelines of the quarantine authorities.”

“Except for Exy and Yeoreum, all Cosmic Girls members and staff underwent rapid antigen testing, and all of them tested negative,” the agency said.

This is Exy’s second time to test positive for Covid-19. She tested positive for Covid-19 for the first time last March 2.

Cignature

In addition, two more members of girl group Cignature tested positive for the virus.

J9 Entertainment announced that Cignature members Belle and Semi tested positive for Covid-19 through a rapid antigen test held on July 24.

It said Belle and Semi have no symptoms and are focusing on self-isolation and home treatment.

Last July 19, Cignature members Chaesol, Seline, Chloe and Dohee tested positive for Covid-19.

South Korea recorded 35,883 new Covid-19 cases on July 25 from 65,433 on July 24 with a daily average for the past week of 65,655.

Related Tags

NCT Mark Cignature Cosmic Girls NCT 127 COVID-19 in South Korea NCT Dream WJSN EXY WJSN
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.